Articles
Viral Vector Vaccine Manufacture: A Glance at the Future on our Doorstep
Today, within the pandemic situation, mRNA or gene therapy is no longer unknown to us. Whether you are a gardener, computer engineer, or dentist, we have all received an accelerated course on how biologics are manufactured. This real-life situation...
Articles
Accelerating Asia’s digital GMP transformation with industry 4.0 technologies
In the IDC Info Brief: "Good Manufacturing Practices for Asia/Pacific Pharmaceutical Companies: Accelerating Transformation with Manufacturing 4.0” published in June 2021 and sponsored by Cognizant and Zenith, IDC analysts found organizations in Asia are working on their Industry 4.0...
Articles
How the Pharmaceutical Industry can keep up with regulatory requirements
Being aware that maintenance has a big influence on both compliance of pharmaceutical processes and the quality of products, observant business owners are beginning to realize the undeniable advantages of controlling and planning maintenance with a Computerized Maintenance Management...
Articles
Samsung Biologics – how are CDMOs affected post Covid commentary
Impact of COVID-19 on Biopharma CDMO Market: Innovation and Investment
The COVID-19 pandemic has strained resources across the globe and impacted nearly every sector. Arguably, it has been most acutely felt in the pharmaceutical space.
While many drug developers and manufacturers...
Articles
AES Clean Technology Post-COVID Supply Chain Commentary
OCT 2021 At AES Clean Technology, we had front-row seats to many of the challenges and triumphs created by the pandemic. There were several factors affecting the supply chain that changed the way we did business, which included direct...
Articles
INCOG: Supply chain commentary
Tedd Green, COO at INCOG Biopharma Services discusses the supply chain challenges that pharmaceutical companies have faced due to the COVID-19 pandemic and what the future of the pharma supply chain looks like.
From shortly after the onset of...
Articles
ChargePoint Technology: Post-COVID Supply Chain Commentary
The pharmaceutical industry and its supply chain have both undergone considerable upheaval due to the COVID-19 pandemic. The closure of factories in Asia producing the bulk of the world’s supply of active pharmaceutical ingredients (APIs) during the first lockdown...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.